These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33125756)

  • 41. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
    Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
    Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial.
    Tapia Rico G; Price T; Tebbutt N; Hardingham J; Lee C; Buizen L; Wilson K; Gebski V; Townsend A
    Clin Colorectal Cancer; 2019 Jun; 18(2):141-148. PubMed ID: 30713134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High- versus low-dose leucovorin in the modified FOLFOX6 regimen for first-line treatment of metastatic colorectal cancer.
    Reynolds J; Chamberland-Tremblay A; Herrington JD; Munoz Maldonado Y; Wong L
    J Oncol Pharm Pract; 2017 Apr; 23(3):173-178. PubMed ID: 26786027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials.
    Oweira H; Giryes A; Mannhart M; Decker M; Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):1069-1074. PubMed ID: 30099922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of primary tumor localization on survival and treatment outcomes in patients with metastatic colorectal cancer-a multicenter study.
    Sahin S; Karatas F
    J BUON; 2019; 24(2):479-487. PubMed ID: 31127994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?
    Price TJ; Beeke C; Ullah S; Padbury R; Maddern G; Roder D; Townsend AR; Moore J; Roy A; Tomita Y; Karapetis C
    Cancer; 2015 Mar; 121(6):830-5. PubMed ID: 25377235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies.
    Gibbs P; Heinemann V; Sharma NK; Taieb J; Ricke J; Peeters M; Findlay M; Robinson B; Jackson C; Strickland A; Gebski V; Van Buskirk M; Zhao H; van Hazel G;
    Clin Colorectal Cancer; 2018 Dec; 17(4):e617-e629. PubMed ID: 30033117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Value of tumor size as a prognostic factor in metastatic colorectal cancer patients after chemotherapy: a population-based study.
    Yan Q; Zhang K; Guo K; Liu S; Wasan HS; Jin H; Yuan L; Feng G; Shen F; Shen M; Ma S; Ruan S
    Future Oncol; 2019 May; 15(15):1745-1758. PubMed ID: 31038364
    [No Abstract]   [Full Text] [Related]  

  • 49. Histopathologic prognostic factors in resected colorectal lung metastases.
    Shiono S; Ishii G; Nagai K; Yoshida J; Nishimura M; Murata Y; Tsuta K; Nishiwaki Y; Kodama T; Ochiai A
    Ann Thorac Surg; 2005 Jan; 79(1):278-82; discussion 283. PubMed ID: 15620957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival in Patients with High-Grade Colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy.
    Fields AC; Lu P; Vierra BM; Hu F; Irani J; Bleday R; Goldberg JE; Nash GM; Melnitchouk N
    Ann Surg Oncol; 2019 Apr; 26(4):1127-1133. PubMed ID: 30706232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes-The University College London Hospital (UCLH) Experience.
    Joharatnam-Hogan N; Wilson W; Shiu KK; Fusai GK; Davidson B; Hochhauser D; Bridgewater J; Khan K
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33261002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry.
    Chong LC; Townsend AR; Young J; Roy A; Piantadosi C; Hardingham JE; Roder D; Karapetis C; Padbury R; Maddern G; Moore J; Price TJ
    Target Oncol; 2019 Feb; 14(1):85-91. PubMed ID: 30659494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is Primary Tumor Excision and Specific Metastases Sites Resection Associated With Improved Survival in Stage Ⅳ Colorectal Cancer? Results From SEER Database Analysis.
    Yi C; Li J; Tang F; Ning Z; Tian H; Xiao L; Wang A; Zong Z
    Am Surg; 2020 May; 86(5):499-507. PubMed ID: 32684032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Short-term outcomes and prognosis of palliative surgery for malignant bowel obstruction caused by peritoneal metastasis of colorectal cancer].
    Chen PJ; Wang L; Chen N; Lu XY; Wang HS; He X; Wang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1051-1057. PubMed ID: 31770836
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies.
    Boeckx N; Koukakis R; Op de Beeck K; Rolfo C; Van Camp G; Siena S; Tabernero J; Douillard JY; André T; Peeters M
    Clin Colorectal Cancer; 2018 Sep; 17(3):170-178.e3. PubMed ID: 29627309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
    da Silva RG; Sugarbaker PH
    J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of treatment modality on clinical outcome in metastatic colorectal cancer patients stratified by metastatic sites.
    Lai HW; Wei JC; Hung HC; Lin CC
    Postgrad Med; 2019 Mar; 131(2):163-170. PubMed ID: 30633608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determinants of survival following hepatic resection for metastatic colorectal cancer.
    Bakalakos EA; Kim JA; Young DC; Martin EW
    World J Surg; 1998 Apr; 22(4):399-404; discussion 404-5. PubMed ID: 9523523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
    Huemer F; Thaler J; Piringer G; Hackl H; Pleyer L; Hufnagl C; Weiss L; Greil R
    BMC Cancer; 2018 Jan; 18(1):11. PubMed ID: 29298682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis.
    Chen X; Hu W; Huang C; Liang W; Zhang J; Wu D; Lv Z; Li Y; Luo Y; Liang Z; Wang M; Wang J; Yao X
    Int J Surg; 2020 Aug; 80():135-152. PubMed ID: 32634480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.